The DEA has forwarded a petition to change the federal regulatory classification for psilocybin, the psychedelic compound found in "magic mushrooms," to HHS for a medical and scientific review. The ...

The Trump administration is set to weigh in on whether the hallucinogenic compound psilocybin should be moved into a less restrictive class of drugs under federal regulations. Regulation of psilocybin ...

An international collaboration led by Cornell researchers used a combination of psilocybin and the rabies virus to map how—and where—the psychedelic compound rewires the connections in the brain.

The Scottsdale Research Institute (SRI) grows psilocybin mushrooms in Arizona with permission from the Drug Enforcement Administration. Late last month, the organization announced that it will use ...

Two paths lead to the same molecule: Independently of each other, different genera of ‘magic mushrooms’ have developed two different enzyme pathways that produce the same psychoactive substance, ...

In a review of previous studies, McMaster University researchers observe a stronger signal for psilocybin as a treatment for obsessive-compulsive disorder than cannabinoids. Obsessive-compulsive ...

Psilocybin, the active ingredient in magic mushrooms, might just revolutionize how depression and anxiety are treated in cancer patients. In a groundbreaking trial, a single dose combined with therapy ...

A hand in a blue glove plucks a white mushroom from a dense stand of mushrooms. Mature magic mushrooms are carefully harvested to minimize damage. Credit: Filament Health Some scientists theorize that ...

Psilocybin, a naturally occurring psychedelic compound found in “magic mushrooms,” has been touted as a potential game-changer for depression and other psychiatric disorders. Over the past two decades ...

In 2016 psychiatrist Benjamin Kelmendi was treating two patients with severe, treatment-resistant obsessive-compulsive disorder (OCD) at a Connecticut mental health center when the patients abruptly ...